|
G |
Ccnb1 |
cyclin B1 |
affects phosphorylation increases expression |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CCNB1 protein 5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased expression of CCNB1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdc25c |
cell division cycle 25C |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CDC25C protein |
CTD |
PMID:21229608 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CDK1 protein |
CTD |
PMID:21229608 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased expression of CDKN1A protein |
CTD |
PMID:21229608 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Foxm1 |
forkhead box M1 |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of FOXM1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Smpd1 |
sphingomyelin phosphodiesterase 1 |
increases activity |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased activity of SMPD1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
|
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
tricin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:16552572 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
chrysoeriol results in decreased activity of ABCC1 protein |
CTD |
PMID:15670588 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Benzo(a)pyrene binds to AHR protein] |
CTD |
PMID:20553787 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP protein] |
CTD |
PMID:20981859 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:20553787 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:20553787 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:20553787 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 protein] |
CTD |
PMID:20981859 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mtnr1a |
melatonin receptor 1A |
affects binding |
ISO |
chrysoeriol binds to MTNR1A protein |
CTD |
PMID:20399199 |
|
NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919
|
|
G |
Mtnr1b |
melatonin receptor 1B |
affects binding |
ISO |
chrysoeriol binds to MTNR1B protein |
CTD |
PMID:20399199 |
|
NCBI chr 8:12,638,219...12,652,737
Ensembl chr 8:12,638,219...12,652,737
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] |
CTD |
PMID:20399199 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
chrysoeriol inhibits the reaction [Hydrogen Peroxide results in increased expression of TNFSF11 protein] |
CTD |
PMID:20981859 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of FOS protein] |
CTD |
PMID:24161485 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein] |
CTD |
PMID:24161485 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein] |
CTD |
PMID:24161485 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of JUN protein] |
CTD |
PMID:24161485 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:24161485 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; [5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]] which results in decreased abundance of Nitric Oxide |
CTD |
PMID:24161485 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]; [5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone |
CTD |
PMID:24161485 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein] |
CTD |
PMID:24161485 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT1 protein]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:24161485 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT3 protein]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:24161485 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein] |
CTD |
PMID:24161485 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
acacetin results in decreased expression of CCNB1 protein |
CTD |
PMID:36740148 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
acacetin results in decreased expression of CCNE1 protein |
CTD |
PMID:36740148 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
acacetin results in decreased expression of CDC25C protein |
CTD |
PMID:36740148 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
acacetin results in decreased expression of CDK1 protein |
CTD |
PMID:36740148 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
acacetin results in decreased expression of CDK2 protein |
CTD |
PMID:36740148 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
acacetin results in increased expression of CDKN1A protein |
CTD |
PMID:36740148 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
acacetin results in increased expression of CHK1 protein |
CTD |
PMID:36740148 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases metabolic processing increases expression decreases activity |
ISO |
CYP1A1 protein results in increased metabolism of acacetin acacetin results in increased expression of CYP1A1 mRNA acacetin results in decreased activity of CYP1A1 protein |
CTD |
PMID:10781868 PMID:21053930 PMID:21482471 PMID:31621310 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO EXP |
acacetin results in decreased activity of CYP1A2 protein |
CTD |
PMID:21053930 PMID:32738202 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases metabolic processing increases expression decreases activity multiple interactions |
ISO |
CYP1B1 protein results in increased metabolism of acacetin acacetin results in increased expression of CYP1B1 mRNA acacetin results in decreased activity of CYP1B1 protein acacetin binds to and results in decreased activity of CYP1B1 protein |
CTD |
PMID:10781868 PMID:21053930 PMID:21482471 PMID:31621310 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP |
acacetin results in decreased activity of CYP2B1 protein |
CTD |
PMID:32738202 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases activity |
EXP |
acacetin results in decreased activity of CYP2C11 protein |
CTD |
PMID:32738202 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
EXP |
acacetin results in decreased activity of CYP2E1 protein |
CTD |
PMID:32738202 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases expression |
EXP ISO |
acacetin results in decreased activity of CYP3A2 protein acacetin binds to and results in decreased activity of CYP3A4 protein; acacetin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; acacetin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] acacetin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:21053930 PMID:29933105 PMID:32738202 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
acacetin results in decreased expression of FADD protein |
CTD |
PMID:36740148 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36740148 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
acacetin results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36740148 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity increases expression multiple interactions |
ISO |
acacetin results in increased activity of NR1I2 protein acacetin results in increased expression of NR1I2 mRNA acacetin results in increased activity of and results in increased expression of NR1I2 protein; sulforaphane inhibits the reaction [acacetin results in increased activity of NR1I2 protein] |
CTD |
PMID:25455453 PMID:29933105 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases expression |
ISO |
acacetin results in increased expression of PARP1 protein |
CTD |
PMID:36740148 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
ISO |
acacetin results in increased expression of RIPK1 protein |
CTD |
PMID:36740148 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
increases expression |
ISO |
acacetin results in increased expression of RIPK3 protein |
CTD |
PMID:36740148 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
ISO |
acacetin results in increased expression of UGT1A1 mRNA |
CTD |
PMID:31621310 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Mitf |
melanocyte inducing transcription factor |
increases expression |
ISO |
afzelin results in increased expression of MITF mRNA; afzelin results in increased expression of MITF protein |
CTD |
PMID:27287415 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Tyr |
tyrosinase |
multiple interactions increases expression |
ISO |
afzelin results in increased expression of and results in increased activity of TYR protein afzelin results in increased expression of TYR mRNA |
CTD |
PMID:27287415 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
increases expression |
ISO |
afzelin results in increased expression of TYRP1 mRNA; afzelin results in increased expression of TYRP1 protein |
CTD |
PMID:27287415 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
|
G |
A2m |
alpha-2-macroglobulin |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Cadmium Chloride results in increased expression of A2M protein] |
CTD |
PMID:15618353 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity multiple interactions |
ISO |
Apigenin results in decreased activity of ABCC1 protein [Glutathione co-treated with Apigenin] affects the reaction [ABCC1 protein results in increased uptake of estradiol-17 beta-glucuronide]; Apigenin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; Apigenin promotes the reaction [ABCC1 protein results in increased uptake of Glutathione]; Glutathione promotes the reaction [Apigenin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]] |
CTD |
PMID:11306701 PMID:12485947 PMID:15670588 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in increased activity of ACHE protein] |
CTD |
PMID:28389404 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ACSL4 mRNA]; Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ACSL4 protein] |
CTD |
PMID:35500696 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Afg3l2 |
AFG3 like matrix AAA peptidase subunit 2 |
increases expression |
ISO |
Apigenin results in increased expression of AFG3L2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr18:60,954,268...60,999,110
Ensembl chr18:60,954,268...60,999,110
|
|
G |
Afp |
alpha-fetoprotein |
affects binding |
EXP |
Apigenin binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
Apigenin binds to and results in increased activity of AHR protein; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [AHR protein binds to AIP protein]]; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]]; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of AHR protein] Apigenin binds to and results in decreased activity of AHR protein; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of AHR protein] |
CTD |
PMID:14644660 PMID:17869316 PMID:20450880 PMID:29584932 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [AHR protein binds to AIP protein]] |
CTD |
PMID:20450880 |
|
NCBI chr 1:201,408,002...201,419,220
Ensembl chr 1:201,407,288...201,419,122
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases expression |
ISO |
[Apigenin co-treated with Fluorouracil] results in decreased expression of AKT1 protein Apigenin results in decreased expression of AKT1 protein |
CTD |
PMID:15947208 PMID:19885610 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
ISO EXP |
[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of APAF1 protein Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of APAF1 mRNA] |
CTD |
PMID:24070738 PMID:30107153 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Apigenin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] |
CTD |
PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap29 |
Rho GTPase activating protein 29 |
increases expression |
ISO |
Apigenin results in increased expression of ARHGAP29 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 2:210,060,036...210,132,572
Ensembl chr 2:210,071,199...210,132,028
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]] Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of ARNT protein] |
CTD |
PMID:20450880 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of ATF6 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of ATF6 protein] |
CTD |
PMID:20493918 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Glutathione inhibits the reaction [Apigenin results in increased expression of ATG7 protein] |
CTD |
PMID:29247770 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
B3galt5 |
Beta-1,3-galactosyltransferase 5 |
increases expression |
ISO |
Apigenin results in increased expression of B3GALT5 protein |
CTD |
PMID:22906706 |
|
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
EXP ISO |
Apigenin results in decreased expression of BAX protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of BAX protein; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of BAX mRNA]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of BAX protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of BAX protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in increased expression of BAX protein]; Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]] [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of BAX mRNA; [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of BAX protein |
CTD |
PMID:24070738 PMID:24144774 PMID:25557508 PMID:30107153 PMID:30152906 PMID:31930969 PMID:35373622 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions decreases response to substance |
ISO EXP |
Apigenin results in decreased expression of BCL2 protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 mRNA]; Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in decreased expression of BCL2 protein]; Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]] [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in decreased expression of BCL2 mRNA; [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in decreased expression of BCL2 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BCL2 protein BCL2 protein results in decreased susceptibility to Apigenin |
CTD |
PMID:15486995 PMID:24070738 PMID:25557508 PMID:29247770 PMID:30107153 PMID:30152906 PMID:31930969 PMID:35373622 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
EXP |
Apigenin results in decreased expression of BCL2L1 protein Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein] |
CTD |
PMID:24144774 PMID:30152906 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] |
CTD |
PMID:28389404 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
ISO |
Apigenin promotes the reaction [Fluorouracil results in increased expression of BECN1 protein]; Fluorouracil promotes the reaction [Apigenin results in increased expression of BECN1 protein] |
CTD |
PMID:28025107 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
EXP |
Apigenin results in increased expression of BID protein |
CTD |
PMID:24144774 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
[TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC2 protein |
CTD |
PMID:29247770 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases cleavage multiple interactions |
ISO |
Apigenin results in increased cleavage of BIRC3 protein [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC3 protein |
CTD |
PMID:15486995 PMID:29247770 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
increases expression |
ISO |
Apigenin results in increased expression of BNIP3L mRNA |
CTD |
PMID:22359648 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Uric Acid results in increased expression of and results in increased cleavage of and results in increased secretion of CASP1 protein modified form] |
CTD |
PMID:29960001 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased activity of CASP12 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased activity of CASP12 protein] |
CTD |
PMID:20493918 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
ISO EXP |
[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP3 mRNA; [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP3 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP3 protein; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein] Apigenin results in increased activity of CASP3 protein Apigenin results in increased cleavage of CASP3 protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP3 protein]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of CASP3 mRNA]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP3 protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in increased expression of CASP3 protein]; Apigenin promotes the reaction [hydroxygenkwanin results in increased activity of CASP3 protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; hydroxygenkwanin promotes the reaction [Apigenin results in increased activity of CASP3 protein] Apigenin inhibits the reaction [Brefeldin A results in increased activity of CASP3 protein]; Apigenin inhibits the reaction [Methotrexate results in increased expression of CASP3 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP3 protein] |
CTD |
PMID:15486995 PMID:17132221 PMID:19397994 PMID:19647729 PMID:19885610 PMID:20493918 PMID:24070738 PMID:24144774 PMID:24148603 PMID:25557508 PMID:28025107 PMID:29247770 PMID:30107153 PMID:30152906 PMID:31930969 PMID:33845614 PMID:35373622 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases cleavage increases activity |
ISO |
Apigenin results in increased cleavage of CASP7 protein Apigenin results in increased activity of CASP7 protein |
CTD |
PMID:15486995 PMID:19647729 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases cleavage multiple interactions increases activity |
ISO EXP |
Apigenin results in increased cleavage of CASP8 protein [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP8 protein Apigenin results in increased activity of CASP8 protein Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP8 protein]; Apigenin promotes the reaction [hydroxygenkwanin results in increased activity of CASP8 protein]; hydroxygenkwanin promotes the reaction [Apigenin results in increased activity of CASP8 protein] |
CTD |
PMID:15486995 PMID:24144774 PMID:29247770 PMID:30152906 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage increases activity multiple interactions |
ISO EXP |
Apigenin results in increased cleavage of CASP9 protein Apigenin results in increased activity of CASP9 protein Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP9 protein]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of CASP9 mRNA]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP9 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form] [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in increased expression of CASP9 mRNA; [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in increased expression of CASP9 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP9 protein |
CTD |
PMID:15486995 PMID:19397994 PMID:24070738 PMID:25557508 PMID:28025107 PMID:29247770 PMID:30107153 PMID:30152906 PMID:31930969 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression multiple interactions increases activity increases expression decreases response to substance |
ISO EXP |
Apigenin results in decreased expression of CAT mRNA Apigenin inhibits the reaction [Methotrexate results in decreased activity of CAT protein] Apigenin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Apigenin inhibits the reaction [Rotenone results in decreased activity of CAT protein] Apigenin results in increased activity of CAT protein Apigenin results in increased expression of CAT mRNA CAT protein results in decreased susceptibility to Apigenin |
CTD |
PMID:21756884 PMID:22359648 PMID:28389404 PMID:30152906 PMID:33845614 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] |
CTD |
PMID:24134915 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression multiple interactions |
ISO |
Apigenin results in increased expression of CCN5 mRNA ESR1 protein inhibits the reaction [Apigenin results in increased expression of CCN5 mRNA] |
CTD |
PMID:23384675 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Apigenin results in decreased expression of CCNB1 mRNA; Apigenin results in decreased expression of CCNB1 protein |
CTD |
PMID:19397994 PMID:26961604 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] |
CTD |
PMID:16601352 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
Apigenin results in decreased expression of CDC25C protein |
CTD |
PMID:26961604 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions decreases expression |
ISO |
Apigenin results in increased phosphorylation of and results in decreased activity of CDK1 protein Apigenin results in decreased expression of CDK1 protein |
CTD |
PMID:11322924 PMID:26872304 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
increases expression |
ISO |
Apigenin results in increased expression of CDKAL1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr17:34,718,701...35,271,276
Ensembl chr17:34,718,687...35,407,524
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO EXP |
Apigenin promotes the reaction [CDKN1A protein binds to PCNA protein]; TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] Apigenin results in increased expression of CDKN1A mRNA Apigenin results in increased expression of CDKN1A mRNA; Apigenin results in increased expression of CDKN1A protein |
CTD |
PMID:11790449 PMID:16023288 PMID:19397994 PMID:26872304 PMID:31201582 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
increases expression |
ISO |
Apigenin results in increased expression of CDKN2C mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
Apigenin results in decreased expression of CEBPB mRNA |
CTD |
PMID:18359623 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases activity |
EXP |
Apigenin results in decreased activity of CES1 protein |
CTD |
PMID:37353134 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cftr |
CF transmembrane conductance regulator |
increases activity affects localization |
ISO |
Apigenin results in increased activity of CFTR protein; Apigenin results in increased activity of CFTR protein mutant form Apigenin affects the localization of CFTR protein mutant form |
CTD |
PMID:15191910 PMID:15277574 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of CHUK protein] |
CTD |
PMID:25935278 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of CKM protein] |
CTD |
PMID:25557508 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clca1 |
chloride channel accessory 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of CLCA1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of COX17 mRNA]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of COX17 protein] |
CTD |
PMID:30107153 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Methotrexate results in increased expression of CRP protein] |
CTD |
PMID:33845614 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Bleomycin results in increased expression of CSF2 mRNA] |
CTD |
PMID:32554301 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Methotrexate results in increased expression of CSF3 protein] |
CTD |
PMID:33845614 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA] |
CTD |
PMID:32554301 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression multiple interactions |
ISO |
Apigenin results in increased expression of CXCL12 mRNA ESR1 protein inhibits the reaction [Apigenin results in increased expression of CXCL12 mRNA] |
CTD |
PMID:23384675 PMID:28396216 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Bleomycin results in increased expression of CXCL1 mRNA] |
CTD |
PMID:32554301 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
ISO EXP |
Apigenin affects the localization of CYCS protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein; Apigenin inhibits the reaction [Isoproterenol results in increased expression of CYCS protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein] [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] affects the localization of CYCS protein |
CTD |
PMID:15486995 PMID:24070738 PMID:30152906 PMID:31930969 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Apigenin results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:31201582 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
decreases expression |
ISO |
Apigenin results in decreased expression of CYP11B1 mRNA |
CTD |
PMID:22172629 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] |
CTD |
PMID:23370353 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity decreases expression |
ISO |
Apigenin results in decreased activity of CYP19A1 protein Apigenin results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:10403137 PMID:15319488 PMID:16023337 PMID:16965912 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases activity increases expression |
ISO |
Apigenin binds to and results in decreased activity of CYP1A1 protein; Apigenin inhibits the reaction [CYP1A1 results in increased activity of Benzo(a)pyrene]; Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Apigenin results in decreased activity of CYP1A1 protein Apigenin results in increased expression of CYP1A1 mRNA Apigenin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Apigenin promotes the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein] |
CTD |
PMID:11454723 PMID:11752233 PMID:16271822 PMID:17012224 PMID:17090139 PMID:20930378 PMID:21053930 PMID:21482471 PMID:26657896 PMID:31621310 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Apigenin results in decreased activity of CYP1A2 protein |
CTD |
PMID:20806393 PMID:21053930 PMID:29753067 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity increases expression multiple interactions increases chemical synthesis |
ISO |
Apigenin results in decreased activity of CYP1B1 protein Apigenin results in increased expression of CYP1B1 mRNA Apigenin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] CYP1B1 protein results in increased chemical synthesis of Apigenin [CYP1B1 protein results in increased metabolism of genkwanin] which results in increased chemical synthesis of Apigenin; Apigenin binds to and results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 PMID:19666078 PMID:20930378 PMID:21053930 PMID:21482471 PMID:31621310 More...
|
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Apigenin inhibits the reaction [Alcohols results in increased expression of CYP2E1 protein] Apigenin results in decreased activity of CYP2E1 protein |
CTD |
PMID:28803762 PMID:29753067 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
ISO |
Apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; Apigenin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] Apigenin results in decreased activity of CYP3A4 protein |
CTD |
PMID:21053930 PMID:29753067 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased expression of DDIT3 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein] |
CTD |
PMID:20493918 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Alcohols results in increased expression of DGAT1 protein] |
CTD |
PMID:28803762 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dhrs11 |
dehydrogenase/reductase 11 |
decreases activity |
ISO |
Apigenin results in decreased activity of DHRS11 protein |
CTD |
PMID:30926317 |
|
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in decreased expression of DRD2 protein] |
CTD |
PMID:28389404 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Duox1 |
dual oxidase 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of DUOX1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
ISO |
Apigenin results in increased expression of EIF5B mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]] |
CTD |
PMID:20153296 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epo |
erythropoietin |
increases expression |
ISO |
Apigenin results in increased expression of EPO mRNA |
CTD |
PMID:37348668 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
[Apigenin co-treated with Fluorouracil] results in decreased expression of ERBB2 protein |
CTD |
PMID:19885610 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased phosphorylation of ERN1 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:20493918 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
increases expression |
ISO |
Apigenin results in increased expression of ERP29 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases phosphorylation increases activity decreases expression affects binding |
ISO EXP |
Apigenin binds to and results in increased activity of ESR1 protein; Apigenin inhibits the reaction [Estradiol binds to ESR1 protein]; ESR1 protein inhibits the reaction [Apigenin results in increased expression of CCN5 mRNA]; ESR1 protein inhibits the reaction [Apigenin results in increased expression of CXCL12 mRNA] Apigenin results in increased phosphorylation of ESR1 protein Apigenin results in increased activity of ESR1 protein Apigenin results in decreased expression of ESR1 protein Apigenin binds to ESR1 protein |
CTD |
PMID:14579009 PMID:16118406 PMID:16541309 PMID:16860978 PMID:17323972 PMID:23384675 PMID:28396216 PMID:29162470 PMID:33049310 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions affects binding increases activity |
ISO |
Apigenin binds to and results in increased activity of ESR2 protein; Apigenin inhibits the reaction [Estradiol binds to ESR2 protein] Apigenin binds to ESR2 protein Apigenin results in increased activity of ESR2 protein |
CTD |
PMID:9751507 PMID:12224631 PMID:16118406 PMID:16860978 PMID:17132221 PMID:33049310 More...
|
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions |
ISO |
Apigenin inhibits the reaction [F2 protein results in increased localization of Calcium] |
CTD |
PMID:19814731 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression multiple interactions |
ISO EXP |
Apigenin results in decreased expression of FAS mRNA Apigenin inhibits the reaction [Isoproterenol results in increased expression of FAS protein] |
CTD |
PMID:18359623 PMID:30152906 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Alcohols results in increased expression of FASN protein] |
CTD |
PMID:28803762 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of FBP1 mRNA |
CTD |
PMID:18331776 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] |
CTD |
PMID:26800359 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Apigenin results in increased expression of FN1 protein |
CTD |
PMID:26408079 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of FOS protein]; Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; Apigenin inhibits the reaction [TNF protein results in increased expression of FOS mRNA] |
CTD |
PMID:15322261 PMID:22634262 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Frmd4a |
FERM domain containing 4A |
increases expression |
ISO |
Apigenin results in increased expression of FRMD4A mRNA |
CTD |
PMID:22359648 |
|
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression multiple interactions |
ISO |
Apigenin results in increased expression of FTH1 mRNA; Apigenin results in increased expression of FTH1 protein Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of FTH1 mRNA]; Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of FTH1 protein] |
CTD |
PMID:35500696 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of FTL mRNA] |
CTD |
PMID:35500696 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased expression of GATA3 mRNA]; Apigenin inhibits the reaction [Ovalbumin results in increased expression of GATA3 protein] |
CTD |
PMID:36350155 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO EXP |
Apigenin results in increased expression of GCLC mRNA [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide Apigenin results in increased expression of GCLC mRNA; Apigenin results in increased expression of GCLC protein |
CTD |
PMID:11864778 PMID:22864849 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression multiple interactions |
EXP |
Apigenin results in increased expression of GCLM mRNA; Apigenin results in increased expression of GCLM protein [Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide |
CTD |
PMID:22864849 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in decreased expression of GDNF mRNA] |
CTD |
PMID:28389404 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of GLI1 mRNA; Apigenin results in decreased expression of GLI1 protein |
CTD |
PMID:20395211 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Methotrexate results in increased activity of GPT protein] |
CTD |
PMID:33845614 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Apigenin results in increased expression of GPX1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression multiple interactions affects binding |
ISO |
Apigenin results in increased expression of GPX4 mRNA; Apigenin results in increased expression of GPX4 protein Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GPX4 mRNA]; Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GPX4 protein] Apigenin binds to GPX4 protein |
CTD |
PMID:35500696 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [Apigenin results in increased expression of GREB1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP ISO |
Apigenin inhibits the reaction [Rotenone results in decreased activity of GSR protein] Apigenin inhibits the reaction [Alcohols results in decreased expression of GSR protein] |
CTD |
PMID:28389404 PMID:28803762 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gypa |
glycophorin A |
increases expression |
ISO |
Apigenin results in increased expression of GYPA protein |
CTD |
PMID:25058688 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Sodium Chloride results in increased expression of HBEGF mRNA] |
CTD |
PMID:26800359 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hexa |
hexosaminidase subunit alpha |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased secretion of HEXA protein] Apigenin inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased secretion of HEXA protein] |
CTD |
PMID:36350155 |
|
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression increases expression multiple interactions decreases activity |
ISO EXP |
Apigenin results in decreased expression of HIF1A protein Apigenin results in increased expression of HIF1A mRNA; Apigenin results in increased expression of HIF1A protein Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]] Apigenin results in decreased activity of HIF1A protein [Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A mRNA; [Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein; Apigenin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Apigenin inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Apigenin results in decreased degradation of and results in increased expression of HIF1A protein modified form; benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [[Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein]; Cycloheximide affects the reaction [[Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein] |
CTD |
PMID:15947208 PMID:19958256 PMID:20153296 PMID:31930969 PMID:35513012 PMID:37348668 More...
|
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]] |
CTD |
PMID:36055550 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression decreases expression |
ISO EXP |
Apigenin inhibits the reaction [Hemin results in increased activity of HMOX1 protein]; Apigenin inhibits the reaction [Hemin results in increased expression of HMOX1 mRNA]; Apigenin inhibits the reaction [Hemin results in increased expression of HMOX1 protein] [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide Apigenin results in increased expression of HMOX1 mRNA; Apigenin results in increased expression of HMOX1 protein Apigenin results in decreased expression of HMOX1 protein |
CTD |
PMID:16109301 PMID:22864849 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
EXP |
Apigenin results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:31201582 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Colforsin results in increased expression of HSD3B2 mRNA] |
CTD |
PMID:23370353 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased expression of HSP90B1 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased expression of HSP90B1 protein] |
CTD |
PMID:20493918 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression |
ISO |
Apigenin results in decreased expression of HSPA1A mRNA |
CTD |
PMID:22359648 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
affects expression |
ISO |
Apigenin affects the expression of HSPA1B mRNA |
CTD |
PMID:22359648 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
decreases expression |
ISO |
Apigenin results in decreased expression of HSPA1L mRNA |
CTD |
PMID:22359648 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
ISO |
Apigenin results in decreased expression of HSPA2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions decreases expression |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] Apigenin results in decreased expression of HSPA5 mRNA |
CTD |
PMID:20493918 PMID:22359648 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO |
Apigenin results in decreased expression of HSPA8 mRNA; Apigenin results in decreased expression of HSPA8 protein |
CTD |
PMID:22359648 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:15113938 PMID:15322261 PMID:16987811 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
decreases expression |
ISO |
Apigenin results in decreased expression of IDH3A mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP ISO |
Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] Apigenin inhibits the reaction [Ovalbumin results in decreased secretion of IFNG protein] |
CTD |
PMID:18090225 PMID:36350155 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IKBKB protein]; Apigenin inhibits the reaction [TNF protein results in increased expression of IKBKB protein]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of IKBKB protein]; Apigenin results in decreased expression of and results in decreased activity of IKBKB protein; Apigenin results in decreased phosphorylation of and results in decreased activity of IKBKB protein; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IKBKB protein]] Apigenin inhibits the reaction [Ovalbumin results in increased phosphorylation of IKBKB protein] Apigenin inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of IKBKB protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:24148603 PMID:25557508 PMID:25935278 PMID:36350155 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA] Apigenin inhibits the reaction [nickel chloride results in increased expression of IL10 protein] |
CTD |
PMID:16934226 PMID:30016632 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL12B protein]] |
CTD |
PMID:28673093 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased secretion of IL13 protein] |
CTD |
PMID:36350155 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Bleomycin results in increased expression of IL1A mRNA] |
CTD |
PMID:32554301 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Apigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA] Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Adenosine Triphosphate results in increased cleavage of and results in increased secretion of IL1B protein]; Apigenin inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]; Apigenin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Apigenin inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Apigenin inhibits the reaction [nickel chloride results in increased expression of IL1B protein]; Apigenin inhibits the reaction [Poly dA-dT results in increased cleavage of and results in increased secretion of IL1B protein]; Apigenin inhibits the reaction [Uric Acid results in increased expression of and results in increased cleavage of and results in increased secretion of IL1B protein]; Apigenin promotes the reaction [Antigens, Bacterial results in increased cleavage of and results in increased secretion of IL1B protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]] Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Apigenin inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in increased expression of IL1B protein] |
CTD |
PMID:15985724 PMID:18090225 PMID:24134915 PMID:25557508 PMID:25935278 PMID:29960001 PMID:30016632 PMID:32554301 PMID:35373622 PMID:36055550 PMID:36350155 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il33 |
interleukin 33 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL33 mRNA]; Apigenin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL33 mRNA] |
CTD |
PMID:37545493 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO |
Apigenin results in decreased expression of IL4 protein Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL4 protein] Apigenin inhibits the reaction [Ovalbumin results in increased secretion of IL4 protein] |
CTD |
PMID:16343431 PMID:36350155 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased secretion of IL5 protein] |
CTD |
PMID:36350155 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
Apigenin inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Apigenin inhibits the reaction [Rotenone results in increased expression of IL6 mRNA] Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL6 mRNA]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Apigenin inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]; Apigenin inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL6 mRNA]]; Apigenin inhibits the reaction [nickel chloride results in increased expression of IL6 protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]] |
CTD |
PMID:24134915 PMID:25557508 PMID:25935278 PMID:28389404 PMID:30016632 PMID:30152906 PMID:32554301 PMID:36055550 PMID:36350155 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP ISO |
Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein] Apigenin inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein]; Apigenin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:18090225 PMID:18591783 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; Apigenin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] |
CTD |
PMID:15322261 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
multiple interactions |
EXP |
(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]]; Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]] |
CTD |
PMID:31930969 |
|
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
|
|
G |
Kdm3a |
lysine demethylase 3A |
increases expression |
ISO |
Apigenin results in increased expression of KDM3A mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
ISO |
[Apigenin co-treated with Oxygen deficiency] affects the phosphorylation of KDR protein |
CTD |
PMID:35513012 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lamb2 |
laminin subunit beta 2 |
increases expression |
ISO |
Apigenin results in increased expression of LAMB2 protein |
CTD |
PMID:26408079 |
|
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
|
|
G |
Lep |
leptin |
increases expression |
ISO |
Apigenin results in increased expression of LEP mRNA; Apigenin results in increased expression of LEP protein |
CTD |
PMID:18359623 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lmbr1l |
limb development membrane protein 1-like |
increases expression |
ISO |
Apigenin results in increased expression of LMBR1L mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 7:130,061,136...130,078,101
Ensembl chr 7:130,061,136...130,076,381
|
|
G |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of LPCAT3 mRNA] |
CTD |
PMID:35500696 |
|
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
|
|
G |
Lrrc26 |
leucine rich repeat containing 26 |
increases expression |
ISO |
Apigenin results in increased expression of LRRC26 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of LTBP1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
|
|
G |
Ltf |
lactotransferrin |
increases expression |
EXP |
Apigenin results in increased expression of LTF protein |
CTD |
PMID:24487097 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form]; Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:29247770 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation increases activity |
ISO EXP |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [[Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; Apigenin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein]; Apigenin results in increased phosphorylation of and results in increased activity of MAPK1 protein Apigenin results in decreased phosphorylation of MAPK1 protein Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] Apigenin results in increased activity of MAPK1 protein |
CTD |
PMID:15322261 PMID:19647729 PMID:22864849 PMID:25557508 PMID:27468969 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO EXP |
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [[Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; Apigenin results in increased phosphorylation of and results in increased activity of MAPK3 protein Apigenin results in decreased phosphorylation of MAPK3 protein Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19647729 PMID:25557508 PMID:27468969 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in increased expression of MAPK8 protein] |
CTD |
PMID:25557508 PMID:35373622 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:25557508 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression multiple interactions |
ISO |
Apigenin results in decreased expression of MCL1 mRNA Apigenin promotes the reaction [Fluorouracil results in decreased expression of MCL1 mRNA]; Fluorouracil promotes the reaction [Apigenin results in decreased expression of MCL1 mRNA] |
CTD |
PMID:28025107 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
decreases phosphorylation |
ISO |
Apigenin results in decreased phosphorylation of MET protein |
CTD |
PMID:27468969 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mib1 |
MIB E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Apigenin results in increased expression of MIB1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr18:1,802,519...1,926,988
Ensembl chr18:1,802,519...1,920,689
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of MMP1 mRNA; Apigenin results in decreased expression of MMP1 protein |
CTD |
PMID:21112745 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
Apigenin results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:26408079 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Bleomycin results in increased expression of MMP3 mRNA] |
CTD |
PMID:32554301 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] |
CTD |
PMID:22634262 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpg |
N-methylpurine-DNA glycosylase |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Methylmercury Compounds results in decreased expression of MPG protein] |
CTD |
PMID:35373622 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP6 mRNA]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP6 protein] |
CTD |
PMID:30107153 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP8 mRNA]; Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP8 protein] |
CTD |
PMID:30107153 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [Apigenin results in increased expression of MYBL1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of MYD88 protein]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of MYD88 protein]]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]] Apigenin inhibits the reaction [Ovalbumin results in increased expression of MYD88 protein] |
CTD |
PMID:36055550 PMID:36350155 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nanog |
Nanog homeobox |
decreases expression |
ISO |
Apigenin results in decreased expression of NANOG protein |
CTD |
PMID:27468969 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in increased expression of NDUFA4 mRNA] |
CTD |
PMID:30107153 |
|
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
|
|
G |
Neo1 |
neogenin 1 |
increases expression |
ISO |
Apigenin results in increased expression of NEO1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
|
|
G |
Nfat5 |
nuclear factor of activated T-cells 5 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Sodium Chloride results in increased expression of NFAT5 mRNA] |
CTD |
PMID:26800359 |
|
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
decreases expression |
EXP |
Apigenin results in decreased expression of NFE2 mRNA |
CTD |
PMID:31201582 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Apigenin affects the localization of and results in increased activity of NFE2L2 protein |
CTD |
PMID:22864849 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions affects localization |
EXP ISO |
Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein]; Apigenin inhibits the reaction [Rotenone results in increased expression of NFKB1 mRNA] Apigenin affects the localization of NFKB1 protein Apigenin inhibits the reaction [TNF protein affects the localization of NFKB1 protein] |
CTD |
PMID:18090225 PMID:24148603 PMID:28389404 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NFKB2 protein] |
CTD |
PMID:25557508 |
|
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions affects degradation |
ISO EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Apigenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]] Apigenin affects the degradation of NFKBIA protein Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of NFKBIA protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in decreased expression of NFKBIA protein] Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Apigenin inhibits the reaction [Ovalbumin results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:15322261 PMID:16934226 PMID:18090225 PMID:24148603 PMID:25557508 PMID:25935278 PMID:36350155 More...
|
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
CTD |
PMID:15322261 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of NLRP3 protein]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of NLRP3 protein]] |
CTD |
PMID:36055550 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Apigenin inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]; PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein]; Apigenin inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] |
CTD |
PMID:11343698 PMID:12512693 PMID:16934226 PMID:18090225 PMID:28389404 PMID:30152906 PMID:33845614 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
Apigenin results in increased activity of NR1I2 protein Apigenin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:25455453 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nsdhl |
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL |
decreases expression |
EXP |
Apigenin results in decreased expression of NSDHL mRNA |
CTD |
PMID:31201582 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Freund's Adjuvant results in increased expression of P2RX7 protein] |
CTD |
PMID:25935278 |
|
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
|
|
G |
Pank2 |
pantothenate kinase 2 |
decreases expression |
ISO |
Apigenin results in decreased expression of PANK2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of PARP1 protein]; Apigenin inhibits the reaction [Cyclosporine results in increased cleavage of PARP1 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of PARP1 protein] Apigenin results in increased cleavage of PARP1 protein [Apigenin co-treated with 3-(4-methylphenylsulfonyl)-2-propenenitrile] results in increased cleavage of PARP1 protein; [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased cleavage of PARP1 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of PARP1 protein |
CTD |
PMID:20493918 PMID:22155090 PMID:24070738 PMID:24148603 PMID:29247770 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Apigenin promotes the reaction [CDKN1A protein binds to PCNA protein] |
CTD |
PMID:26872304 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
[Apigenin co-treated with Oxygen deficiency] affects the phosphorylation of PDGFRB protein |
CTD |
PMID:35513012 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pgr |
progesterone receptor |
affects binding multiple interactions |
ISO |
Apigenin binds to PGR protein Apigenin inhibits the reaction [Progesterone binds to PGR protein] |
CTD |
PMID:14579009 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate] |
CTD |
PMID:25388478 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of PKMYT1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Polr2h |
RNA polymerase II, I and III subunit H |
increases expression |
ISO |
Apigenin results in increased expression of POLR2H mRNA |
CTD |
PMID:22359648 |
|
NCBI chr11:80,192,017...80,197,468
Ensembl chr11:80,192,032...80,197,515 Ensembl chr10:80,192,032...80,197,515
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of POU5F1 protein |
CTD |
PMID:22906706 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Alcohols results in decreased expression of PPARA protein] |
CTD |
PMID:28803762 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression |
ISO |
Apigenin binds to and results in increased activity of PPARG protein; PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] Apigenin results in decreased expression of PPARG mRNA |
CTD |
PMID:11343698 PMID:18359623 PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] |
CTD |
PMID:16873680 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prom1 |
prominin 1 |
decreases expression |
ISO |
Apigenin results in decreased expression of PROM1 protein |
CTD |
PMID:27468969 |
|
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Prpsap1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
increases expression |
ISO |
Apigenin results in increased expression of PRPSAP1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr10:101,701,094...101,750,753
Ensembl chr10:101,701,096...101,750,751
|
|
G |
Psca |
prostate stem cell antigen |
decreases expression |
ISO |
Apigenin results in decreased expression of PSCA mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO EXP |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PTGS2 mRNA]; Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PTGS2 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] Apigenin results in decreased expression of PTGS2 protein Apigenin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] Apigenin affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:11343698 PMID:16552572 PMID:30152906 PMID:35500696 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Uric Acid results in increased phosphorylation of PTK2B protein] |
CTD |
PMID:29960001 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Uric Acid promotes the reaction [PYCARD protein binds to PYCARD protein]] |
CTD |
PMID:29960001 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Ranbp10 |
RAN binding protein 10 |
increases expression |
ISO |
Apigenin results in increased expression of RANBP10 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr19:33,656,046...33,716,864
Ensembl chr19:33,656,046...33,717,033
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions affects localization |
ISO EXP |
Apigenin results in increased expression of RELA protein Apigenin inhibits the reaction [Alcohols results in increased expression of RELA protein] Apigenin affects the localization of RELA protein Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of RELA protein]; Apigenin inhibits the reaction [TNF protein affects the localization of RELA protein] Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein]; Apigenin inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of RELA protein] |
CTD |
PMID:15090468 PMID:15113938 PMID:18090225 PMID:22634262 PMID:24148603 PMID:25935278 PMID:28803762 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rnase3 |
ribonuclease A family member 3 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased secretion of RNASE3 protein] |
CTD |
PMID:36350155 |
|
NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases expression |
ISO |
Apigenin results in decreased expression of RPS6KB1 protein |
CTD |
PMID:15947208 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of S1PR1 protein] |
CTD |
PMID:25557508 |
|
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of S1PR2 protein] |
CTD |
PMID:25557508 |
|
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
|
|
G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of S1PR3 protein] |
CTD |
PMID:25557508 |
|
NCBI chr17:13,781,050...13,794,408
Ensembl chr17:13,781,050...13,794,505
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of SDHA mRNA] |
CTD |
PMID:30107153 |
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
Apigenin inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:15113938 PMID:16987811 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sf3b2 |
splicing factor 3b, subunit 2 |
increases expression |
ISO |
Apigenin results in increased expression of SF3B2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 1:202,570,423...202,590,774
Ensembl chr 1:202,570,423...202,590,759
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
Apigenin binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Slain2 |
SLAIN motif family, member 2 |
increases expression |
ISO |
Apigenin results in increased expression of SLAIN2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr14:35,236,034...35,314,186
Ensembl chr14:35,236,041...35,304,678
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
[Apigenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions decreases expression |
ISO |
Apigenin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose] Apigenin results in decreased expression of SLC2A1 mRNA; Apigenin results in decreased expression of SLC2A1 protein |
CTD |
PMID:36870413 PMID:37437745 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
multiple interactions decreases expression |
ISO |
[Apigenin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA Apigenin results in decreased expression of SLC2A3 mRNA; Apigenin results in decreased expression of SLC2A3 protein |
CTD |
PMID:20153296 PMID:37437745 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein] |
CTD |
PMID:18591783 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
multiple interactions decreases expression |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC3A2 mRNA] Apigenin results in decreased expression of SLC3A2 mRNA |
CTD |
PMID:35500696 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
multiple interactions |
ISO |
Apigenin analog inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside] |
CTD |
PMID:17495124 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC7A11 mRNA] |
CTD |
PMID:35500696 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] |
CTD |
PMID:22394605 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slf2 |
SMC5-SMC6 complex localization factor 2 |
decreases expression |
ISO |
Apigenin results in decreased expression of SLF2 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 1:243,782,786...243,845,418
Ensembl chr 1:243,782,246...243,845,250
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in increased expression of SNCA protein] |
CTD |
PMID:28389404 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
increases expression |
ISO |
Apigenin results in increased expression of SOCS3 mRNA |
CTD |
PMID:23782265 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression multiple interactions |
ISO |
Apigenin results in decreased expression of SOD1 mRNA; Apigenin results in decreased expression of SOD1 protein Apigenin inhibits the reaction [Methotrexate results in decreased activity of SOD1 protein] |
CTD |
PMID:22359648 PMID:33845614 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
decreases expression |
ISO |
Apigenin results in decreased expression of SOX2 protein |
CTD |
PMID:27468969 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sphk1 |
sphingosine kinase 1 |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of SPHK1 protein] |
CTD |
PMID:25557508 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
increases expression |
ISO |
Apigenin results in increased expression of SPTBN1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Alcohols results in increased expression of SREBF1 protein] |
CTD |
PMID:28803762 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation multiple interactions |
ISO |
Apigenin results in decreased phosphorylation of STAT3 protein Apigenin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:20153296 PMID:27468969 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases sulfation |
ISO |
SULT1A1 protein SNP results in increased sulfation of Apigenin |
CTD |
PMID:17293380 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Progesterone results in increased expression of SULT1E1 mRNA] |
CTD |
PMID:22414680 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Syk |
spleen associated tyrosine kinase |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Uric Acid results in increased phosphorylation of SYK protein] |
CTD |
PMID:29960001 |
|
NCBI chr17:12,604,615...12,678,437
Ensembl chr17:12,604,619...12,661,410
|
|
G |
Tbx21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in decreased expression of TBX21 mRNA]; Apigenin inhibits the reaction [Ovalbumin results in decreased expression of TBX21 protein] |
CTD |
PMID:36350155 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
G |
Tecr |
trans-2,3-enoyl-CoA reductase |
increases expression |
ISO |
Apigenin results in increased expression of TECR mRNA |
CTD |
PMID:22359648 |
|
NCBI chr19:24,526,700...24,568,168
Ensembl chr19:24,541,615...24,568,168
|
|
G |
Tfpt |
TCF3 fusion partner |
decreases expression |
ISO |
Apigenin results in decreased expression of TFPT mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 1:65,587,633...65,597,407
Ensembl chr 1:65,582,359...65,611,689
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TFRC protein] |
CTD |
PMID:35500696 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
Apigenin inhibits the reaction [Rotenone results in decreased expression of TH protein] |
CTD |
PMID:28389404 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Apigenin binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
Apigenin binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF6 protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IKBKB protein]]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]] Apigenin inhibits the reaction [Ovalbumin results in increased expression of TLR4 protein] |
CTD |
PMID:36350155 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tm7sf2 |
transmembrane 7 superfamily member 2 |
decreases expression |
EXP |
Apigenin results in decreased expression of TM7SF2 mRNA |
CTD |
PMID:31201582 |
|
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of TNF mRNA]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of TNF mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Apigenin inhibits the reaction [nickel chloride results in increased expression of TNF protein]; Apigenin inhibits the reaction [TNF protein affects the localization of NFKB1 protein]; Apigenin inhibits the reaction [TNF protein affects the localization of RELA protein]; Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; Apigenin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein]; Apigenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [TNF protein results in increased expression of FOS mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Apigenin inhibits the reaction [TNF protein results in increased expression of IKBKB protein]; Apigenin inhibits the reaction [TNF protein results in increased expression of JUN mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of SELE protein]; Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of IKBKB protein]; Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] Apigenin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Apigenin inhibits the reaction [Methylmercury Compounds results in increased expression of TNF protein]; Apigenin inhibits the reaction [Rotenone results in increased expression of TNF mRNA]; Apigenin promotes the reaction [hydroxygenkwanin results in increased expression of TNF protein]; hydroxygenkwanin promotes the reaction [Apigenin results in increased expression of TNF protein] Apigenin inhibits the reaction [Alcohols results in increased expression of TNF protein]; Apigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA] |
CTD |
PMID:15113938 PMID:15322261 PMID:15985724 PMID:16987811 PMID:24144774 PMID:24148603 PMID:25557508 PMID:25935278 PMID:28389404 PMID:28803762 PMID:30016632 PMID:30152906 PMID:35373622 PMID:36055550 PMID:36350155 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
ISO |
[TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BCL2 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC2 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC3 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP3 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP8 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP9 protein; [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of PARP1 protein |
CTD |
PMID:29247770 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions affects activity increases expression |
ISO |
TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] Apigenin affects the activity of TP53 protein Apigenin results in increased expression of TP53 protein |
CTD |
PMID:11790449 PMID:16023288 PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i3 |
tumor protein p53 inducible protein 3 |
increases expression |
ISO |
Apigenin results in increased expression of TP53I3 mRNA; Apigenin results in increased expression of TP53I3 protein |
CTD |
PMID:19397994 |
|
NCBI chr 6:27,818,327...27,825,753
|
|
G |
Tp63 |
tumor protein p63 |
increases expression |
ISO |
Apigenin results in increased expression of TP63 protein |
CTD |
PMID:19397994 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tp73 |
tumor protein p73 |
increases expression |
ISO |
Apigenin results in increased expression of TP73 protein |
CTD |
PMID:19397994 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [Ovalbumin results in increased expression of TRAF6 protein] Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF6 protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF6 protein]] |
CTD |
PMID:36350155 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
increases expression |
ISO |
Apigenin results in increased expression of TUBB5 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Tyr |
tyrosinase |
increases expression |
ISO |
Apigenin results in increased expression of TYR mRNA |
CTD |
PMID:21071833 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression increases glucuronidation multiple interactions |
ISO |
Apigenin results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of Apigenin 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Apigenin results in increased expression of UGT1A1 mRNA]; [sulforaphane co-treated with Apigenin] results in increased expression of UGT1A1 mRNA |
CTD |
PMID:14557274 PMID:15090468 PMID:29584932 PMID:31621310 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Apigenin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of Apigenin |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
G |
Uqcrq |
ubiquinol-cytochrome c reductase, complex III subunit VII |
multiple interactions |
EXP |
Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of UQCRQ mRNA] |
CTD |
PMID:30107153 |
|
NCBI chr10:37,585,864...37,589,328
Ensembl chr10:37,586,888...37,589,169
|
|
G |
Usp48 |
ubiquitin specific peptidase 48 |
increases expression |
ISO |
Apigenin results in increased expression of USP48 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 5:149,800,189...149,867,838
Ensembl chr 5:149,800,179...149,867,719
|
|
G |
Utrn |
utrophin |
increases expression |
ISO |
Apigenin results in increased expression of UTRN mRNA |
CTD |
PMID:22028826 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:15113938 PMID:16987811 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions |
ISO |
Apigenin results in decreased expression of VEGFA mRNA; Apigenin results in decreased expression of VEGFA protein [Apigenin co-treated with Oxygen deficiency] affects the expression of VEGFA mRNA; [Apigenin co-treated with Oxygen deficiency] affects the expression of VEGFA protein; Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; Apigenin inhibits the reaction [Oxygen deficiency results in increased secretion of VEGFA protein] |
CTD |
PMID:15947208 PMID:20153296 PMID:35513012 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif containing 1 |
increases expression |
ISO |
Apigenin results in increased expression of ZCRB1 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 7:124,525,227...124,538,564
Ensembl chr 7:124,524,870...124,571,261
|
|
G |
Zfp110 |
zinc finger protein 110 |
increases expression |
ISO |
Apigenin results in increased expression of ZFP110 mRNA |
CTD |
PMID:22359648 |
|
NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086
|
|
|
G |
Gypa |
glycophorin A |
increases expression |
ISO |
apigetrin results in increased expression of GYPA protein |
CTD |
PMID:25058688 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression multiple interactions increases activity |
ISO |
baicalein results in increased expression of ABCB1 protein baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; baicalein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; baicalein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] baicalein results in increased activity of ABCB1 protein |
CTD |
PMID:34217736 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
baicalein results in decreased activity of ABCC1 protein |
CTD |
PMID:15670588 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of ACTA2 protein baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] |
CTD |
PMID:30201452 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Afp |
alpha-fetoprotein |
affects binding |
EXP |
baicalein binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects response to substance increases activity increases expression |
ISO |
AHR protein affects the reaction [baicalein results in decreased phosphorylation of RB1 protein]; baicalein binds to and results in increased activity of AHR protein AHR protein affects the susceptibility to baicalein baicalein results in increased activity of AHR protein baicalein results in increased expression of AHR protein |
CTD |
PMID:14644660 PMID:17869316 PMID:22820424 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]]; baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein] |
CTD |
PMID:37783230 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation affects binding increases phosphorylation multiple interactions |
ISO |
baicalein results in decreased phosphorylation of AKT1 protein baicalein binds to AKT1 protein baicalein results in increased phosphorylation of AKT1 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of AKT1 mRNA]; Lithium Chloride inhibits the reaction [baicalein results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [baicalein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18025287 PMID:22820424 PMID:36988316 PMID:38230788 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
multiple interactions decreases activity |
ISO |
baicalein inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] baicalein results in decreased activity of ALOX12 protein |
CTD |
PMID:17027136 PMID:23238474 |
|
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
decreases activity |
ISO |
baicalein results in decreased activity of ALOX15 protein |
CTD |
PMID:23238474 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
EXP |
baicalein inhibits the reaction [APP protein binds to APP protein] |
CTD |
PMID:17323972 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ascl3 |
achaete-scute family bHLH transcription factor 3 |
affects expression |
ISO |
baicalein affects the expression of ASCL3 protein |
CTD |
PMID:36055377 |
|
NCBI chr 1:163,755,306...163,755,951
Ensembl chr 1:163,754,956...163,759,682
|
|
G |
Ascl4 |
achaete-scute family bHLH transcription factor 4 |
affects expression |
ISO |
baicalein affects the expression of ASCL4 protein |
CTD |
PMID:36055377 |
|
NCBI chr 7:17,940,972...17,943,215
Ensembl chr 7:17,941,709...17,942,146
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF4 protein] |
CTD |
PMID:33779329 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression multiple interactions |
EXP |
baicalein results in increased expression of ATF5 protein [Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF5 protein |
CTD |
PMID:33779329 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein] |
CTD |
PMID:33779329 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atf7 |
activating transcription factor 7 |
multiple interactions |
EXP |
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein |
CTD |
PMID:33779329 |
|
NCBI chr 7:133,660,491...133,750,902
Ensembl chr 7:133,663,294...133,750,848
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of BAX protein modified form]; baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein] baicalein results in increased expression of BAX protein |
CTD |
PMID:20850421 PMID:21457722 PMID:37783230 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]; baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein] baicalein results in decreased expression of BCL2 protein MIR3663 mRNA promotes the reaction [baicalein results in decreased expression of BCL2 protein] |
CTD |
PMID:20850421 PMID:33838155 PMID:37783230 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
EXP |
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of BECN1 protein baicalein results in increased expression of BECN1 protein |
CTD |
PMID:33779329 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
SB 203580 inhibits the reaction [baicalein results in decreased expression of BIRC5 protein]; wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein] |
CTD |
PMID:18025287 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP3 protein modified form]; baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein] |
CTD |
PMID:20850421 PMID:37783230 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] |
CTD |
PMID:20850421 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
EXP |
baicalein results in decreased expression of CCNA1 protein |
CTD |
PMID:11513834 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO EXP |
baicalein results in decreased expression of CCNA2 protein |
CTD |
PMID:11513834 PMID:21457722 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
baicalein results in decreased expression of CCNB1 protein |
CTD |
PMID:18025287 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression increases expression |
ISO |
Lithium Chloride inhibits the reaction [baicalein results in decreased expression of CCND1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA] |
CTD |
PMID:19160421 PMID:21457722 PMID:22820424 PMID:24560969 PMID:36988316 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
EXP |
baicalein results in decreased expression of CCND2 protein |
CTD |
PMID:11513834 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression increases expression |
ISO EXP |
baicalein results in decreased expression of CCNE1 protein baicalein results in increased expression of CCNE1 protein |
CTD |
PMID:11513834 PMID:24560969 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases phosphorylation decreases expression multiple interactions |
ISO EXP |
baicalein results in decreased phosphorylation of CDK1 protein baicalein results in decreased expression of CDK1 protein SB 203580 inhibits the reaction [baicalein results in decreased phosphorylation of CDK1 protein]; wortmannin promotes the reaction [baicalein results in decreased phosphorylation of CDK1 protein] |
CTD |
PMID:11513834 PMID:18025287 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
baicalein results in decreased expression of CDK2 protein |
CTD |
PMID:11513834 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
ISO |
baicalein results in increased expression of CDK4 protein |
CTD |
PMID:22820424 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO EXP |
baicalein inhibits the reaction [Mitomycin results in increased expression of CDKN1A protein] baicalein results in increased expression of CDKN1A protein |
CTD |
PMID:11513834 PMID:34624459 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
EXP |
baicalein results in increased expression of CDKN2B protein |
CTD |
PMID:11513834 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
baicalein results in decreased expression of CEBPA protein |
CTD |
PMID:24560969 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
baicalein results in decreased expression of CEBPB mRNA |
CTD |
PMID:24560969 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
decreases expression |
ISO |
baicalein results in decreased expression of CEBPG mRNA |
CTD |
PMID:24560969 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] |
CTD |
PMID:20850421 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cftr |
CF transmembrane conductance regulator |
increases activity |
ISO |
baicalein results in increased activity of CFTR protein |
CTD |
PMID:15234961 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]]; baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein] |
CTD |
PMID:30201452 PMID:37783230 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
EXP |
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Csf2 |
colony stimulating factor 2 |
decreases expression |
ISO |
baicalein results in decreased expression of CSF2 mRNA |
CTD |
PMID:10718847 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of CTNNB1 protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of CTNNB1 protein] |
CTD |
PMID:38317500 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] affects the localization of CYCS protein] |
CTD |
PMID:20850421 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression decreases expression multiple interactions increases chemical synthesis decreases activity |
ISO |
baicalein results in increased expression of CYP1A1 protein baicalein results in decreased expression of CYP1A1 mRNA [CYP1A1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; baicalein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] CYP1A1 protein results in increased chemical synthesis of baicalein baicalein results in decreased activity of CYP1A1 protein |
CTD |
PMID:12224597 PMID:14644660 PMID:18451504 PMID:19666078 PMID:21053930 PMID:21482471 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity increases chemical synthesis multiple interactions |
ISO |
baicalein results in decreased activity of CYP1A2 protein CYP1A2 protein results in increased chemical synthesis of baicalein [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein |
CTD |
PMID:19666078 PMID:21053930 PMID:29753067 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity increases chemical synthesis multiple interactions |
ISO |
baicalein results in decreased activity of CYP1B1 protein CYP1B1 protein results in increased chemical synthesis of baicalein [CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; baicalein binds to and results in decreased activity of CYP1B1 protein; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:12224597 PMID:19666078 PMID:21053930 PMID:21482471 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
baicalein results in increased expression of CYP2B6 mRNA |
CTD |
PMID:25625231 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
baicalein results in decreased activity of CYP2C19 protein |
CTD |
PMID:29753067 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO |
baicalein results in decreased activity of CYP2E1 protein |
CTD |
PMID:29753067 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
baicalein results in decreased activity of CYP3A4 protein |
CTD |
PMID:21053930 PMID:29753067 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of DDIT3 protein] |
CTD |
PMID:33779329 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
decreases expression |
ISO |
baicalein results in decreased expression of DGAT1 protein |
CTD |
PMID:24560969 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
increases expression |
ISO |
baicalein results in increased expression of DLK1 mRNA |
CTD |
PMID:24560969 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
baicalein inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions affects binding decreases phosphorylation |
ISO |
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of EGFR mRNA]; baicalein inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of EGFR protein] baicalein binds to EGFR protein |
CTD |
PMID:25625231 PMID:33838155 PMID:38230788 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr2 |
early growth response 2 |
decreases expression |
ISO |
baicalein results in decreased expression of EGR2 mRNA |
CTD |
PMID:24560969 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF2AK3 protein] |
CTD |
PMID:33779329 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Epo |
erythropoietin |
increases expression |
ISO |
baicalein results in increased expression of EPO mRNA |
CTD |
PMID:37348668 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases expression |
ISO |
baicalein results in decreased expression of and results in decreased phosphorylation of ERBB2 protein baicalein results in decreased expression of ERBB2 mRNA |
CTD |
PMID:36988316 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ERN1 protein] |
CTD |
PMID:33779329 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
baicalein binds to ESR1 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in decreased expression of ESR1 mRNA] |
CTD |
PMID:38230788 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
baicalein results in decreased expression of FABP4 protein |
CTD |
PMID:24560969 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
baicalein results in decreased expression of FASN protein |
CTD |
PMID:24560969 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] |
CTD |
PMID:30201452 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Mitomycin results in increased activity of GLB1 protein] |
CTD |
PMID:34624459 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO |
baicalein results in decreased expression of GLI1 mRNA; baicalein results in decreased expression of GLI1 protein |
CTD |
PMID:20395211 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
decreases expression |
ISO |
baicalein results in decreased expression of GPAT3 protein |
CTD |
PMID:24560969 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
affects expression multiple interactions |
ISO |
baicalein affects the expression of GPX4 protein baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]] |
CTD |
PMID:36055377 PMID:37354967 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation multiple interactions |
ISO |
baicalein results in decreased phosphorylation of GSK3B protein baicalein inhibits the reaction [Mitomycin results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:22820424 PMID:34624459 PMID:36988316 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hey2 |
hes-related family bHLH transcription factor with YRPW motif 2 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
ISO |
baicalein results in decreased degradation of and results in increased expression of HIF1A protein modified form baicalein results in increased expression of HIF1A mRNA; baicalein results in increased expression of HIF1A protein |
CTD |
PMID:37348668 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
baicalein results in increased expression of HMOX1 mRNA; baicalein results in increased expression of HMOX1 protein baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]; baicalein inhibits the reaction [Polymyxin B results in increased expression of HMOX1 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]] Hemin promotes the reaction [baicalein results in increased expression of HMOX1 protein]; HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] |
CTD |
PMID:14563492 PMID:37354967 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions increases activity |
ISO |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [baicalein results in increased activity of HSD11B2 protein] |
CTD |
PMID:18032417 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 protein] |
CTD |
PMID:33779329 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein] |
CTD |
PMID:17458902 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B protein] baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of IL1B protein] |
CTD |
PMID:22369883 PMID:38230788 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of IL6 protein] |
CTD |
PMID:38230788 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions increases secretion |
ISO |
baicalein promotes the reaction [Glucose results in increased secretion of INS protein] baicalein results in increased secretion of INS protein |
CTD |
PMID:17192482 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions affects binding |
ISO |
baicalein inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of JUN mRNA] baicalein binds to JUN protein |
CTD |
PMID:17458902 PMID:38230788 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klf2 |
KLF transcription factor 2 |
increases expression |
ISO |
baicalein results in increased expression of KLF2 mRNA |
CTD |
PMID:24560969 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klf5 |
KLF transcription factor 5 |
decreases expression |
ISO |
baicalein results in decreased expression of KLF5 mRNA |
CTD |
PMID:24560969 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Lpin1 |
lipin 1 |
decreases expression |
ISO |
baicalein results in decreased expression of LPIN1 protein |
CTD |
PMID:24560969 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions affects binding decreases phosphorylation |
ISO |
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of MAPK1 mRNA]; baicalein results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of MAPK1 protein] baicalein binds to MAPK1 protein baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK1 protein modified form]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:10718847 PMID:20850421 PMID:31811862 PMID:33838155 PMID:38230788 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
baicalein results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of MAPK3 protein] baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK3 protein modified form]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:10718847 PMID:20850421 PMID:31811862 PMID:33838155 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
baicalein results in decreased phosphorylation of and results in decreased activity of MAPK8 protein |
CTD |
PMID:10718847 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mir1224 |
microRNA 1224 |
increases expression |
ISO |
baicalein results in increased expression of MIR1224 mRNA |
CTD |
PMID:33838155 |
|
NCBI chr11:80,306,902...80,306,986
Ensembl chr11:80,306,902...80,306,986
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
ISO |
baicalein inhibits the reaction [TGFB1 protein results in increased expression of MIR21 mRNA]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] |
CTD |
PMID:30201452 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir322 |
microRNA 322 |
increases expression |
ISO |
baicalein results in increased expression of MIR424 mRNA |
CTD |
PMID:33838155 |
|
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases activity multiple interactions |
ISO |
baicalein results in decreased activity of MMP2 protein baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP2 mRNA] |
CTD |
PMID:21803068 PMID:22369883 PMID:36988316 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression decreases activity |
ISO |
baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of MMP9 protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] baicalein results in decreased activity of MMP9 protein |
CTD |
PMID:19804834 PMID:21803068 PMID:22369883 PMID:38317500 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein] |
CTD |
PMID:27780710 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
baicalein results in decreased phosphorylation of and results in decreased activity of MTOR protein |
CTD |
PMID:24560969 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nat1 |
N-acetyltransferase 1 |
decreases expression |
ISO |
baicalein results in decreased expression of NAT1 mRNA; baicalein results in decreased expression of NAT1 protein |
CTD |
PMID:15796204 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases localization |
ISO |
baicalein results in decreased localization of NFKB1 protein |
CTD |
PMID:21803068 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions decreases phosphorylation |
ISO |
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of NFKBIA protein] baicalein results in decreased phosphorylation of NFKBIA protein |
CTD |
PMID:20850421 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
decreases phosphorylation |
ISO |
baicalein results in decreased phosphorylation of NFKBIB protein |
CTD |
PMID:21803068 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
ISO |
baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein]; baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Hemin promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]]; tin protoporphyrin IX inhibits the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] baicalein results in decreased expression of NOS2 protein |
CTD |
PMID:14563492 PMID:20850421 PMID:22369883 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
increases activity increases expression |
ISO |
baicalein results in increased activity of NOTCH1 protein baicalein results in increased expression of NOTCH1 mRNA |
CTD |
PMID:19160421 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects localization |
ISO |
baicalein affects the localization of NR1I3 protein |
CTD |
PMID:25625231 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
ISO |
STMN1 protein inhibits the reaction [baicalein results in decreased expression of PCNA protein] |
CTD |
PMID:38317500 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
multiple interactions |
EXP |
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of PIK3C3 protein |
CTD |
PMID:33779329 |
|
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
affects binding multiple interactions |
ISO |
baicalein binds to PIK3CA protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of PIK3CA mRNA] |
CTD |
PMID:38230788 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases activity |
ISO |
baicalein results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
multiple interactions |
ISO |
baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK1 protein]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31811862 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases activity |
ISO |
baicalein results in decreased activity of PLAU protein |
CTD |
PMID:21803068 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Fenretinide results in increased expression of PMAIP1 mRNA] |
CTD |
PMID:17216584 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
baicalein results in decreased expression of PPARG protein |
CTD |
PMID:24560969 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkca |
protein kinase C, alpha |
decreases phosphorylation |
ISO |
baicalein results in decreased phosphorylation of PRKCA protein |
CTD |
PMID:21803068 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA]; baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein]; baicalein inhibits the reaction [Polymyxin B results in increased expression of PTGS2 protein] |
CTD |
PMID:19804834 PMID:22369883 PMID:31811862 PMID:37354967 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pygb |
glycogen phosphorylase B |
decreases activity |
ISO |
baicalein results in decreased activity of PYGB protein |
CTD |
PMID:37277066 |
|
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
|
|
G |
Pygl |
glycogen phosphorylase L |
decreases activity |
ISO |
baicalein results in decreased activity of PYGL protein |
CTD |
PMID:37277066 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions decreases phosphorylation |
ISO |
AHR protein affects the reaction [baicalein results in decreased phosphorylation of RB1 protein]; Lithium Chloride inhibits the reaction [baicalein results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:22820424 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases phosphorylation affects localization decreases localization |
ISO |
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] affects the localization of RELA protein]; baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of RELA protein] baicalein results in decreased phosphorylation of RELA protein MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of RELA protein]; NKILA mRNA promotes the reaction [baicalein affects the localization of RELA protein] baicalein results in decreased localization of RELA protein |
CTD |
PMID:20850421 PMID:21803068 PMID:22369883 PMID:29481769 PMID:33838155 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
baicalein results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein |
CTD |
PMID:24560969 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Sh3gl1 |
SH3 domain containing GRB2 like 1, endophilin A2 |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of SH3GL1 mRNA; baicalein results in decreased expression of SH3GL1 protein MIR3663 mRNA promotes the reaction [baicalein results in decreased expression of SH3GL1 protein] |
CTD |
PMID:33838155 |
|
NCBI chr 9:842,285...869,753
Ensembl chr 9:842,288...869,716
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Polymyxin B results in decreased expression of SIRT1 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]] |
CTD |
PMID:37354967 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
baicalein results in decreased activity of SLC22A6 protein |
CTD |
PMID:32159797 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
ISO |
baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]] |
CTD |
PMID:37354967 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
baicalein inhibits the reaction [SNCA protein binds to SNCA protein] baicalein inhibits the reaction [Rotenone promotes the reaction [SNCA protein binds to SNCA protein]]; baicalein inhibits the reaction [Rotenone results in increased expression of SNCA protein] |
CTD |
PMID:27425033 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Spry1 |
sprouty RTK signaling antagonist 1 |
multiple interactions |
ISO |
baicalein inhibits the reaction [TGFB1 protein results in decreased expression of SPRY1 protein]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] |
CTD |
PMID:30201452 |
|
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
affects binding multiple interactions |
ISO |
baicalein binds to SRC protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of SRC mRNA] |
CTD |
PMID:38230788 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
baicalein results in decreased expression of SREBF1 protein |
CTD |
PMID:24560969 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
baicalein inhibits the reaction [TGFB1 protein results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:30201452 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of STMN1 protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of CTNNB1 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of MMP9 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of PCNA protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of WNT3A protein] |
CTD |
PMID:38317500 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]] baicalein inhibits the reaction [TGFB1 protein results in decreased expression of SPRY1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of MIR21 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased phosphorylation of STAT3 protein]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] |
CTD |
PMID:19474275 PMID:30201452 PMID:37783230 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
baicalein inhibits the reaction [Rotenone results in decreased expression of TH protein] |
CTD |
PMID:27425033 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of TNF protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of TNF protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF protein] |
CTD |
PMID:20850421 PMID:22369883 PMID:38230788 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression affects binding multiple interactions |
ISO EXP |
baicalein results in increased expression of TP53 protein baicalein binds to TP53 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of TP53 mRNA]; baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]] |
CTD |
PMID:11513834 PMID:21457722 PMID:37354967 PMID:38230788 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
baicalein results in decreased expression of VEGFA protein |
CTD |
PMID:16638750 PMID:36988316 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wnt3a |
Wnt family member 3A |
decreases expression multiple interactions |
ISO |
baicalein results in decreased expression of WNT3A protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of WNT3A protein] |
CTD |
PMID:38317500 |
|
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
EXP |
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 protein] |
CTD |
PMID:33779329 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein] |
CTD |
PMID:34044073 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased activity of XIAP protein] |
CTD |
PMID:20850421 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases expression |
EXP |
baicalin results in increased expression of and results in increased activity of ACHE protein baicalin results in increased expression of ACHE mRNA |
CTD |
PMID:27019979 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity |
ISO |
baicalin results in increased activity of AHR protein |
CTD |
PMID:17869316 PMID:26204831 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein] |
CTD |
PMID:38016618 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of ALB protein] |
CTD |
PMID:35088608 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP |
baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein] |
CTD |
PMID:20139896 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Angpt1 |
angiopoietin 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in decreased expression of ANGPT1 mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:24312512 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
baicalin results in increased expression of BAX protein baicalin affects the reaction [Rotenone results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Rotenone results in increased expression of BAX protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX protein] baicalin inhibits the reaction [Rotenone affects the expression of BAX protein] |
CTD |
PMID:21457722 PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein] baicalin results in decreased expression of BCL2 protein baicalin affects the reaction [Rotenone results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] |
CTD |
PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
baicalin inhibits the reaction [Rotenone affects the expression of CASP3 protein] baicalin affects the reaction [Rotenone results in decreased activity of CASP3 protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; baicalin inhibits the reaction [Gentamicins results in increased cleavage of CASP3 protein] |
CTD |
PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
baicalin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein] |
CTD |
PMID:34333357 PMID:35088608 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
baicalin results in decreased expression of CCNA2 protein |
CTD |
PMID:21457722 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression decreases expression multiple interactions |
ISO |
baicalin results in increased expression of CCND1 mRNA baicalin results in decreased expression of CCND1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] |
CTD |
PMID:19160421 PMID:21457722 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
EXP |
baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 protein]; baicalin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] baicalin results in increased expression of CYP1A1 mRNA; baicalin results in increased expression of CYP1A1 protein |
CTD |
PMID:18451504 PMID:26204831 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 protein |
CTD |
PMID:26204831 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:25625231 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:29031535 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
ISO |
baicalin results in decreased expression of FOXA2 mRNA; baicalin results in decreased expression of FOXA2 protein |
CTD |
PMID:32687838 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein] |
CTD |
PMID:15645217 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP ISO |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein] |
CTD |
PMID:15645217 PMID:35088608 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression multiple interactions |
ISO |
baicalin results in increased expression of HES1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression multiple interactions |
ISO |
baicalin results in increased expression of HEY1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hey2 |
hes-related family bHLH transcription factor with YRPW motif 2 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO EXP |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HMOX1 protein]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 mRNA]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein] baicalin results in increased expression of HMOX1 mRNA; baicalin results in increased expression of HMOX1 protein |
CTD |
PMID:16824337 PMID:18187930 PMID:38016618 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf1a |
HNF1 homeobox A |
multiple interactions decreases expression |
ISO |
baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF1A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein] baicalin results in decreased expression of HNF1A mRNA; baicalin results in decreased expression of HNF1A protein |
CTD |
PMID:32687838 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression multiple interactions |
ISO |
baicalin results in decreased expression of HNF4A protein baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein]; HNF4A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens] baicalin results in decreased expression of HNF4A mRNA; baicalin results in decreased expression of HNF4A protein |
CTD |
PMID:32687838 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of HSPB1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]] baicalin inhibits the reaction [Rotenone results in increased expression of IL1B protein] |
CTD |
PMID:29031535 PMID:35088608 PMID:36446982 PMID:38016618 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
EXP ISO |
baicalin results in decreased expression of IL6 mRNA; baicalin results in decreased expression of IL6 protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein] |
CTD |
PMID:22019745 PMID:29031535 PMID:34333357 PMID:35088608 PMID:38016618 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Itga4 |
integrin subunit alpha 4 |
multiple interactions |
EXP |
baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein]; baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein] |
CTD |
PMID:36731809 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:35088608 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
EXP |
baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein] |
CTD |
PMID:36731809 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein] |
CTD |
PMID:38016618 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:34414639 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
decreases expression |
EXP |
baicalin results in decreased expression of MYD88 protein |
CTD |
PMID:22019745 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
EXP |
baicalin results in increased expression of NFKBIA protein |
CTD |
PMID:22019745 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]] |
CTD |
PMID:29031535 PMID:38016618 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
EXP ISO |
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; mifobate inhibits the reaction [baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] baicalin results in decreased expression of NOS2 mRNA; baicalin results in decreased expression of NOS2 protein baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] |
CTD |
PMID:18187930 PMID:22019745 PMID:24312512 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
increases activity increases expression |
ISO |
baicalin results in increased activity of NOTCH1 protein baicalin results in increased expression of NOTCH1 mRNA |
CTD |
PMID:19160421 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
ISO |
Baicalin increases expression of NR1H3 mRNA and protein in foam cells |
RGD |
PMID:27389392 |
RGD:401842390 |
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases activity |
ISO |
baicalin results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] |
CTD |
PMID:24312512 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prima1 |
proline rich membrane anchor 1 |
increases expression |
EXP |
baicalin results in increased expression of PRIMA1 mRNA |
CTD |
PMID:27019979 |
|
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:122,338,370...122,389,921
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
EXP |
baicalin results in decreased expression of PTGS2 mRNA; baicalin results in decreased expression of PTGS2 protein |
CTD |
PMID:22019745 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
baicalin affects the localization of and results in decreased expression of RELA protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:22019745 PMID:34333357 PMID:38016618 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:35088608 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tek |
TEK receptor tyrosine kinase |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in decreased expression of TEK mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases expression multiple interactions |
ISO |
baicalin results in decreased expression of TFAM mRNA baicalin inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA] |
CTD |
PMID:36446982 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in decreased expression of TGFB1 mRNA]; baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 PMID:34414639 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TH protein] |
CTD |
PMID:38016618 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tlr4 |
toll-like receptor 4 |
decreases expression multiple interactions |
EXP ISO |
baicalin results in decreased expression of TLR4 protein baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TLR4 protein] baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:22019745 PMID:24312512 PMID:34333357 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO EXP |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] baicalin results in decreased expression of TNF mRNA; baicalin results in decreased expression of TNF protein baicalin inhibits the reaction [Paraquat results in increased expression of TNF protein] |
CTD |
PMID:16824337 PMID:18187930 PMID:22019745 PMID:34333357 PMID:35088608 PMID:38016618 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
baicalin results in increased expression of TP53 protein |
CTD |
PMID:21457722 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions |
ISO |
baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]] |
CTD |
PMID:29031535 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Usp27x |
ubiquitin specific peptidase 27, X-linked |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in increased expression of USP27X protein] |
CTD |
PMID:34414639 |
|
NCBI chr X:15,123,620...15,126,855
Ensembl chr X:15,124,596...15,125,912
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein] |
CTD |
PMID:36731809 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfc |
vascular endothelial growth factor C |
multiple interactions |
EXP |
baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
baicalin inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein] |
CTD |
PMID:34044073 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity increases metabolic processing increases expression |
ISO |
cirsiliol results in decreased activity of CYP1A1 protein CYP1A1 protein results in increased metabolism of cirsiliol cirsiliol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:19601638 PMID:21482471 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression increases metabolic processing decreases activity |
ISO |
cirsiliol results in increased expression of CYP1B1 mRNA CYP1B1 protein results in increased metabolism of cirsiliol cirsiliol results in decreased activity of CYP1B1 protein |
CTD |
PMID:19601638 PMID:21482471 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
cudraflavone B results in increased expression of BAX protein resveratrol inhibits the reaction [cudraflavone B results in increased expression of BAX protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of BAX protein] |
CTD |
PMID:23881456 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
resveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein]; sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein] |
CTD |
PMID:23881456 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO |
cudraflavone B results in increased activity of CASP3 protein resveratrol inhibits the reaction [cudraflavone B results in increased activity of CASP3 protein]; sirtinol promotes the reaction [cudraflavone B results in increased activity of CASP3 protein] |
CTD |
PMID:23881456 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
cudraflavone B results in increased expression of CDKN1A protein resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1A protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1A protein] |
CTD |
PMID:23881456 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases expression |
ISO |
resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] |
CTD |
PMID:23881456 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases activity |
ISO |
cudraflavone B results in increased activity of MAPK1 protein |
CTD |
PMID:23881456 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases activity |
ISO |
cudraflavone B results in increased activity of MAPK3 protein |
CTD |
PMID:23881456 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
cudraflavone B results in increased phosphorylation of and results in increased degradation of NFKBIA protein |
CTD |
PMID:23881456 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions decreases phosphorylation |
ISO |
resveratrol inhibits the reaction [cudraflavone B results in decreased phosphorylation of RB1 protein]; sirtinol promotes the reaction [cudraflavone B results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:23881456 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization |
ISO |
cudraflavone B affects the localization of RELA protein |
CTD |
PMID:23881456 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression multiple interactions |
ISO |
cudraflavone B results in increased expression of SIRT1 mRNA; cudraflavone B results in increased expression of SIRT1 protein resveratrol promotes the reaction [cudraflavone B results in increased expression of SIRT1 mRNA]; resveratrol promotes the reaction [cudraflavone B results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 mRNA]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 protein] |
CTD |
PMID:23881456 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
cudraflavone B results in increased expression of TP53 protein resveratrol inhibits the reaction [cudraflavone B results in increased expression of TP53 protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of TP53 protein] |
CTD |
PMID:23881456 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
diosmetin results in decreased activity of ABCC1 protein |
CTD |
PMID:15670588 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand affects the expression of ACP5 mRNA] |
CTD |
PMID:36563736 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form] |
CTD |
PMID:35191607 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]] |
CTD |
PMID:35191607 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity increases response to substance multiple interactions |
ISO |
diosmetin results in decreased activity of CYP1A1 protein CYP1A1 protein results in increased susceptibility to diosmetin [CYP1A1 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin |
CTD |
PMID:10781868 PMID:21482471 PMID:33727136 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases response to substance |
ISO |
diosmetin results in decreased activity of CYP1A2 protein [CYP1A2 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin CYP1A2 protein results in increased susceptibility to diosmetin |
CTD |
PMID:28867436 PMID:33727136 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
diosmetin results in decreased activity of CYP1B1 protein |
CTD |
PMID:10781868 PMID:21482471 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
diosmetin results in decreased activity of CYP2C19 protein |
CTD |
PMID:28867436 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity |
ISO |
diosmetin results in decreased activity of CYP2C8 protein |
CTD |
PMID:28867436 |
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO |
diosmetin results in decreased activity of CYP2E1 protein |
CTD |
PMID:28867436 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam] |
CTD |
PMID:18191104 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] |
CTD |
PMID:18191104 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein] |
CTD |
PMID:35191607 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein] |
CTD |
PMID:35191607 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein] |
CTD |
PMID:35191607 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of KEAP1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]] |
CTD |
PMID:35191607 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36563736 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:36563736 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36563736 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:36563736 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [RANK Ligand affects the expression of NFATC1 mRNA] |
CTD |
PMID:36563736 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFE2L2 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]] |
CTD |
PMID:35191607 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
diosmetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:16934226 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein] |
CTD |
PMID:35191607 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:16934226 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NQO1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein] |
CTD |
PMID:35191607 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]] |
CTD |
PMID:35191607 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases activity |
ISO |
diosmetin results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
EXP |
diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein] |
CTD |
PMID:35191607 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
[diosmetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:28867436 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
multiple interactions |
ISO |
diosmetin inhibits the reaction [SLCO1A2 protein results in increased uptake of Rosuvastatin Calcium] |
CTD |
PMID:28867436 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
diosmetin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:16934226 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
Diosmin binds to and results in increased activity of AHR protein |
CTD |
PMID:14644660 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of AR protein] |
CTD |
PMID:31797688 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of BAD protein] |
CTD |
PMID:21477647 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein] |
CTD |
PMID:32061149 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP ISO |
[Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] |
CTD |
PMID:21477647 PMID:32061149 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP3 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of CASP3 protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein] |
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 PMID:32061149 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of CAT protein]; Diosmin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; Diosmin inhibits the reaction [Testosterone Propionate results in decreased activity of CAT protein] |
CTD |
PMID:22056647 PMID:23665045 PMID:31797688 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of CEACAM1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP2E1 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Eno2 |
enolase 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of and results in decreased activity of GPX1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of GSR protein]; Diosmin inhibits the reaction [Testosterone Propionate results in decreased activity of GSR protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSR protein] |
CTD |
PMID:23665045 PMID:31797688 PMID:32061149 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of IL6 protein] Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of IL6 protein] |
CTD |
PMID:31797688 PMID:32061149 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of KLK3 protein] |
CTD |
PMID:31797688 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Diosmin inhibits the reaction [Acetic Acid results in increased activity of MPO protein] |
CTD |
PMID:29187079 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein] |
CTD |
PMID:23665045 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of PARP1 protein] |
CTD |
PMID:32061149 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein] |
CTD |
PMID:23665045 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGER2 protein] |
CTD |
PMID:35920545 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of PTGS2 protein]; Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of PTGS2 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein] |
CTD |
PMID:23665045 PMID:29187079 PMID:31797688 PMID:32061149 PMID:35920545 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of RELA protein] |
CTD |
PMID:32061149 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of TNF protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of TNF protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein] |
CTD |
PMID:23665045 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
EXP ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of XDH protein]; Diosmin inhibits the reaction [Testosterone Propionate results in increased activity of XDH protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of XDH protein] |
CTD |
PMID:23665045 PMID:31797688 PMID:32061149 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression increases activity multiple interactions |
ISO |
galangin results in increased expression of ABCB1 mRNA; galangin results in increased expression of ABCB1 protein galangin results in increased activity of ABCB1 protein galangin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; Verapamil promotes the reaction [galangin results in increased activity of ABCB1 protein] |
CTD |
PMID:26238175 PMID:34217736 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
galangin results in decreased activity of ABCC1 protein |
CTD |
PMID:15670588 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
EXP |
galangin results in decreased activity of ACHE protein |
CTD |
PMID:20452337 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity multiple interactions affects localization |
ISO |
galangin results in increased activity of AHR protein galangin affects the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; galangin binds to and results in decreased activity of AHR protein; galangin binds to and results in increased activity of AHR protein; galangin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]; galangin inhibits the reaction [Benzo(a)pyrene affects the localization of AHR protein]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of AHR protein] galangin affects the localization of AHR protein |
CTD |
PMID:10953044 PMID:14644660 PMID:17090139 PMID:20435555 PMID:20450880 PMID:33663268 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
galangin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:18455702 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of ARNT mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of ARNT protein] |
CTD |
PMID:33663268 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atg12 |
autophagy related 12 |
increases expression multiple interactions |
ISO |
galangin results in increased expression of ATG12 mRNA; galangin results in increased expression of ATG12 protein [ATG12 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG12 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG12 protein] |
CTD |
PMID:25268046 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
multiple interactions increases expression |
ISO |
[ATG16L1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG16L1 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG16L1 protein] galangin results in increased expression of ATG16L1 mRNA; galangin results in increased expression of ATG16L1 protein |
CTD |
PMID:25268046 |
|
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atg3 |
autophagy related 3 |
multiple interactions increases expression |
ISO |
[ATG3 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG3 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG3 protein] galangin results in increased expression of ATG3 mRNA; galangin results in increased expression of ATG3 protein |
CTD |
PMID:25268046 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
galangin results in increased expression of BAX protein |
CTD |
PMID:25450235 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
galangin results in decreased expression of BCL2 protein |
CTD |
PMID:25450235 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
galangin results in decreased expression of BCL2L1 protein |
CTD |
PMID:25450235 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
galangin inhibits the reaction [Doxorubicin results in decreased expression of BDNF protein] |
CTD |
PMID:35843304 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
ISO |
[BECN1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of BECN1 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of BECN1 protein] galangin results in increased expression of BECN1 mRNA; galangin results in increased expression of BECN1 protein |
CTD |
PMID:25268046 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO EXP |
galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein] galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of and results in increased activity of CASP1 protein] |
CTD |
PMID:23535185 PMID:35384154 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
ISO |
[ATG12 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [ATG16L1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [ATG3 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [BECN1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein galangin results in increased cleavage of CASP3 protein |
CTD |
PMID:25268046 PMID:25450235 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions |
EXP ISO |
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein] galangin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] |
CTD |
PMID:33663268 PMID:35384154 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
galangin results in decreased expression of CCND1 protein |
CTD |
PMID:25450235 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
galangin results in decreased expression of CDK4 protein |
CTD |
PMID:25450235 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
galangin results in decreased expression of CDK6 protein |
CTD |
PMID:25450235 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
galangin results in increased expression of CDKN1A protein |
CTD |
PMID:25450235 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
ISO |
galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYB5A protein] |
CTD |
PMID:33663268 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression decreases activity |
ISO |
galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] galangin results in increased expression of CYP1A1 mRNA galangin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] galangin results in decreased activity of CYP1A1 protein |
CTD |
PMID:10953044 PMID:17090139 PMID:20930378 PMID:21053930 PMID:33663268 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
ISO |
galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] galangin results in decreased activity of CYP1A2 protein |
CTD |
PMID:17090139 PMID:20806393 PMID:21053930 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
galangin binds to and results in decreased activity of CYP1B1 protein galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:21053930 PMID:33663268 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
galangin results in increased expression of CYP2B6 mRNA |
CTD |
PMID:25625231 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression multiple interactions increases activity decreases activity |
ISO |
galangin results in increased expression of CYP3A4 mRNA [[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; galangin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; galangin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] galangin results in decreased activity of CYP3A4 protein |
CTD |
PMID:21053930 PMID:26238175 PMID:31756459 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
galangin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; galangin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
galangin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:25625231 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
ISO |
galangin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
galangin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]] |
CTD |
PMID:20153296 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions increases expression |
ISO |
ferrous sulfate inhibits the reaction [galangin results in increased expression of EPAS1 protein]; Iron inhibits the reaction [galangin results in increased expression of EPAS1 protein] |
CTD |
PMID:17973296 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Esr1 |
estrogen receptor 1 |
increases phosphorylation |
EXP |
galangin results in increased phosphorylation of ESR1 protein |
CTD |
PMID:17323972 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
galangin inhibits the reaction [Doxorubicin results in increased expression of GFAP protein] |
CTD |
PMID:35843304 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Glo1 |
glyoxalase 1 |
multiple interactions |
ISO |
galangin results in decreased expression of and results in decreased activity of GLO1 protein |
CTD |
PMID:29113808 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of GSR protein] |
CTD |
PMID:35384154 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases activity |
ISO |
galangin results in decreased activity of GSTP1 protein |
CTD |
PMID:15041478 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HAVCR1 protein] |
CTD |
PMID:35384154 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|